Ruthenium Complexes with Pyridazine Carboxylic Acid: Synthesis, Characterization, and Anti-Biofilm Activity.

As a result of drug resistance, many antimicrobial medicines become ineffective, making the infections more difficult to treat. Therefore, there is a need to develop new compounds with antibacterial activity. This role may be played, for example, by metal complexes with carboxylic acids.

Synthesis, Characterization and Biological Investigations of Half-Sandwich Ruthenium(II) Complexes Containing Benzimidazole Moiety.

Half-sandwich Ru(II) complexes belong to group of biologically active metallo-compounds with promising antimicrobial and anticancer activity. Herein, we report the synthesis and characterization of arene ruthenium complexes containing benzimidazole moiety, namely, [(η--cymene)RuCl(bimCOO)] () and [(η--cymene)RuCl(bim)] () (where bimCOO = benzimidazole-2-carboxylate and bim = 1--benzimidazole). The compounds were characterized by H NMR, C NMR, IR, UV-vis and CV.

Ruthenium Complexes with 2-Pyridin-2-yl-1-benzimidazole as Potential Antimicrobial Agents: Correlation between Chemical Properties and Anti-Biofilm Effects.

Antimicrobial resistance is a growing public health concern that requires urgent action. Biofilm-associated resistance to antimicrobials begins at the attachment phase and increases as the biofilms maturate. Hence, interrupting the initial binding process of bacteria to surfaces is essential to effectively prevent biofilm-associated problems.

Tuning Anti-Biofilm Activity of Manganese(II) Complexes: Linking Biological Effectiveness of Heteroaromatic Complexes of Alcohol, Aldehyde, Ketone, and Carboxylic Acid with Structural Effects and Redox Activity.

The constantly growing resistance of bacteria to antibiotics and other antibacterial substances has led us to an era in which alternative antimicrobial therapies are urgently required. One promising approach is to target bacterial pathogens using metal complexes. Therefore, we investigated the possibility of utilizing series of manganese(II) complexes with heteroaromatic ligands: Alcohol, aldehyde, ketone, and carboxylic acid as inhibitors for biofilm formation of .

Ruthenium(IV) Complexes as Potential Inhibitors of Bacterial Biofilm Formation.

With increasing antimicrobial resistance there is an urgent need for new strategies to control harmful biofilms. In this study, we have investigated the possibility of utilizing ruthenium(IV) complexes (HO)(HL1)[RuCl]·2Cl·2EtOH () and [RuCl(CHCN)](L2)·HO () (where L1-2-hydroxymethylbenzimadazole, L2-1,4-dihydroquinoxaline-2,3-dione) as effective inhibitors for biofilms formation. The biological activities of the compounds were explored using , , PAO1, and LES B58.

Synthesis, Structural Characterization and Antimicrobial Evaluation of Ruthenium Complexes with Heteroaromatic Carboxylic Acids.

The antibacterial and antibiofilm activities of two new ruthenium complexes against E. coli, S. aureus, P.

A benzimidazole-based ruthenium(IV) complex inhibits Pseudomonas aeruginosa biofilm formation by interacting with siderophores and the cell envelope, and inducing oxidative stress.

Pseudomonas aeruginosa biofilm-associated infections are a serious medical problem, and new compounds and therapies acting through novel mechanisms are much needed. Herein, the authors report a ruthenium(IV) complex that reduces P. aeruginosa PAO1 biofilm formation by 84%, and alters biofilm morphology and the living-to-dead cell ratio at 1 mM concentration.

Morphological changes in Proteus mirabilis O18 biofilm under the influence of a urease inhibitor and a homoserine lactone derivative.

Proteus mirabilis is a pathogenic gram-negative bacterium that frequently causes kidney infections, typically established by ascending colonization of the urinary tract. The present study is focused on ureolytic activity and urease inhibition in biofilms generated by P. mirabilis O18 cells.

Ruthenium complexes in different oxidation states: synthesis, crystal structure, spectra and redox properties.

The reactions of a mother solution of RuCl(3) with benzimidazole derivatives 2-(2'-pyridyl)benzimidazole (2,2'-PyBIm, L(1)) and 2-hydroxymethylbenzimidazole (2-CH(2)OHBIm, L(2)) yielded three novel ruthenium complexes: (H(2)L(1))(2)[Ru(III)Cl(4)(CH(3)CN)(2)](2)[Ru(IV)Cl(4)(CH(3)CN)(2)]·2Cl·6H(2)O (1), mer-[Ru(III)Cl(3)L(1)(CH(3)CN)]·L(1)·3H(2)O (2), and (HL(2))(4)[Ru(IV)Cl(6)]·2Cl·4H(2)O (3). The isolated compounds were characterised by elemental analyses, UV-Vis and IR spectroscopy, and magnetic measurements. The nature of the ligands bound to the metal ions of these compounds and the experimental conditions significantly influenced the ruthenium complexes in different oxidation states.